• Fed. Trade Comm'n v. Vyera Pharm. LLC

    Publication Date: 2021-11-17
    Practice Area: Antitrust | Evidence
    Industry: Federal Government | Pharmaceuticals
    Court: U.S. District Court for the Southern District of New York, U.S. - SDNY
    Judge: District Judge Denise Cote
    Attorneys: For plaintiff: For Plaintiff Federal Trade Commission: James H. Weingarten, Markus H. Meier, Bradley S. Albert, Amanda Triplett, Armine Black, Daniel W. Butrymowicz, J. Maren Schmidt, Lauren Peay, Leah Hubinger, Matthew B. Weprin, Neal J. Perlman, Federal Trade Commission, Washington, DC. For Plaintiff State of New York: Amy E. McFarlane, Jeremy R. Kasha, Elinor R. Hoffman, Saami Zain, Office of the New York Attorney General, Antitrust Bureau, New York, NY. Bryan Lewis Bloom, Freshfields Bruckhaus Deringer US LLP, Washington, DC. For Plaintiff State of California: Michael D. Battaglia, Office of the Attorney General of California, San Francisco, CA. For Plaintiff State of Ohio: Beth Finnerty, Office of the Ohio Attorney General, Columbus, OH. For Plaintiff Commonwealth of Pennsylvania: Joseph Betsko, Pennsylvania Office of Attorney General, Harrisburg, PA. For Plaintiff State of Illinois: Richard S. Schultz, Office of the Attorney General of Illinois, Chicago, IL. For Plaintiff State of North Carolina: K.D. Sturgis, Jessica V. Sutton, North Carolina Dept. of Justice, Consumer Protection Division, Raleigh, NC. For Plaintiff Commonwealth of Virginia: Sarah Oxenham Allen, Tyler T. Henry, Office of the Attorney General of Virginia, Richmond, VA.
    for defendant: For Defendants Vyera Pharmaceuticals, LLC and Phoenixus AG: Stacey Anne Mahoney, Sarah E. Hsu Wilbur, Morgan, Lewis & Bockius LLP, New York, NY. Scott A. Stempel, William Cravens, Melina R. Dimattio, Morgan, Lewis & Bockius LLP, Washington, D.C. Steven A. Reed, Morgan, Lewis & Bockius LLP, Philadelphia, PA. Noah J. Kaufman, Morgan, Lewis & Bockius LLP, Boston, MA. Michael M. Elliott, Rachel J. Rodriguez, Phillips Nizer LLP, New York, NY. Michael L. Weiner, Dechert LLP (NYC), New York, NY. For Defendant Martin Shkreli: Christopher H. Casey, Andrew J. Rudowitz, Jeffrey S. Pollack, Sarah O'Laughlin Kulik, Duane Morris LLP, Philadelphia, PA. Sarah Fehm Stewart, Duane Morris, LLP (NJ), Newark, NJ. For Defendant Kevin Mulleady: Kenneth R. David, Albert Shemtov Mishaan, Nicholas Anthony Rendino, Kasowitz, Benson, Torres LLP (NYC), New York, NY.

    Case Number: 20-CV-00706

    Evidence of Anticompetitive Strategy's Prior Use Admissible as Background, Motive Evidence

  • November 12, 2021 | The Recorder

    On the Move: Tracking the Ins and Outs of California Lawyers

    New hires, promotions and awards from across the California legal market.

    4 minute read

  • Andre-Rodney v. Hochul

    Publication Date: 2021-11-05
    Practice Area: Civil Rights | Covid-19
    Industry: State and Local Government
    Court: U.S. District Court for the Northern District of New York, U.S. - NDNY
    Judge: District Judge Brenda Sannes
    Attorneys: For plaintiff: For Plaintiffs: Dennis C. Vacco, Scott S. Allen Jr., Lippes Mathias Wexler Friedman LLP, Buffalo, NY.
    for defendant: For Defendants: Letitia James, Attorney General of the State of New York, Jorge A. Rodriguez, Brittany M. Haner, Assistant Attorneys General, of Counsel, The Capitol, Albany, NY.

    Case Number: 1:21-CV-1053

    Hospital Security Workers Lose Constitutional Challenge to Covid-19 Vaccination Mandate

  • November 3, 2021 | Law.com

    Critical Mass by Law.com's Amanda Bronstad: Bankruptcy Battle Begins Tomorrow Over Talc Lawsuits. California Judge Finds Opioid Companies Did Not Create a Public Nuisance

    A bankruptcy judge has set two days of hearings on whether to grant an injunction that would halt lawsuits over Johnson & Johnson's talc-based baby powder. A tentative decision on Monday found a group of California governments failed to distinguish legitimate reasons to prescribe opioids from illegal uses. And find out who SoClean hired to represent it in lawsuits over its CPAP cleaning devices.

    6 minute read

  • October 21, 2021 | Law.com

    A Shadow Over Science? How the Pandemic Changed—Or Didn't Change—Jurors

    Some lawyers who have handled trials this year say the COVID-19 pandemic has clouded how jurors perceive scientific and medical testimony, but others aren't convinced that juries have changed that much. More apparent, lawyers say, is that the political polarization surrounding the pandemic has seeped into the jury pool.

    13 minute read

  • October 6, 2021 | Law.com

    Critical Mass by Law.com's Amanda Bronstad: Lawsuits Over Montana Train Crash Rail Against Both Amtrak and BNSF. Johnson & Johnson's Talc Tally Is Now Four Verdicts in a Row

    At least five lawsuits have been filed over the Sept. 25 derailment of an Amtrak train in Montana. And after a defense verdict in a Georgia talc trial, could jurors have a different view of science coming out of the pandemic?

    7 minute read

  • October 1, 2021 | The Recorder

    Big Law Bulks Up on 'High-End' Partners in LA

    Wilson Sonsini, Blank Rome and Greenberg Traurig all made Southern California hires this week.

    5 minute read

  • September 28, 2021 | The Legal Intelligencer

    'Battle of the Experts': How J&J Won Its Talc Trial in Plaintiff-Friendly Philadelphia

    Leigh O'Dell, an attorney with Beasley Allen, said the plaintiffs' side is still processing the recent verdicts and will be revisiting its strategy and examining questions such as whether COVID has changed juror attitudes.

    5 minute read

  • September 24, 2021 | The Legal Intelligencer

    Phila. Jury Hands Up Defense Verdict in Suit Linking J&J Talc Products to Cancer

    The verdict came at the end of the first trial in the Philadelphia Court of Common Pleas to test the plaintiffs' theory about talc.

    4 minute read

  • September 22, 2021 | New York Law Journal

    Board Structure Is Key to Oversight

    In this edition of their Corporate Governance column, David A. Katz and Laura A. McIntosh write that boards of directors should thoughtfully review their board committee structures to determine if there is sufficient management oversight of mission-critical company and industry risks and, where appropriate, consider reallocating responsibilities among various board committees, with corresponding updates to committee charters.

    9 minute read